JP2015119730A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015119730A5 JP2015119730A5 JP2015055989A JP2015055989A JP2015119730A5 JP 2015119730 A5 JP2015119730 A5 JP 2015119730A5 JP 2015055989 A JP2015055989 A JP 2015055989A JP 2015055989 A JP2015055989 A JP 2015055989A JP 2015119730 A5 JP2015119730 A5 JP 2015119730A5
- Authority
- JP
- Japan
- Prior art keywords
- virus
- seq
- sequence
- segment
- nos
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261605922P | 2012-03-02 | 2012-03-02 | |
| US61/605,922 | 2012-03-02 | ||
| US201261685766P | 2012-03-23 | 2012-03-23 | |
| US61/685,766 | 2012-03-23 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013548864A Division JP6054883B2 (ja) | 2012-03-02 | 2013-03-02 | インフルエンザウイルスの再集合 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015119730A JP2015119730A (ja) | 2015-07-02 |
| JP2015119730A5 true JP2015119730A5 (enExample) | 2016-10-13 |
| JP6279503B2 JP6279503B2 (ja) | 2018-02-14 |
Family
ID=47997362
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013548864A Active JP6054883B2 (ja) | 2012-03-02 | 2013-03-02 | インフルエンザウイルスの再集合 |
| JP2015055989A Active JP6279503B2 (ja) | 2012-03-02 | 2015-03-19 | インフルエンザウイルスの再集合 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013548864A Active JP6054883B2 (ja) | 2012-03-02 | 2013-03-02 | インフルエンザウイルスの再集合 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US9422528B2 (enExample) |
| EP (1) | EP2820126B1 (enExample) |
| JP (2) | JP6054883B2 (enExample) |
| CN (1) | CN103608453B (enExample) |
| AU (1) | AU2013205478B9 (enExample) |
| CA (1) | CA2813723A1 (enExample) |
| ES (1) | ES2628301T3 (enExample) |
| WO (1) | WO2013087945A2 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10130697B2 (en) | 2010-03-23 | 2018-11-20 | Wisconsin Alumni Research Foundation (Warf) | Vaccines comprising mutant attenuated influenza viruses |
| ES2655051T3 (es) | 2011-08-26 | 2018-02-16 | Wisconsin Alumni Research Foundation | Virus de la gripe con segmento génico PB2 mutante como vacunas vivas atenuadas |
| US20140274806A1 (en) | 2013-03-15 | 2014-09-18 | Synthetic Genomics Vaccines | Influenza virus reassortment |
| MX2015009330A (es) * | 2013-01-23 | 2016-04-15 | Novartis Ag | Reordenamiento del virus de influenza. |
| JP2016521553A (ja) * | 2013-06-06 | 2016-07-25 | ノバルティス アーゲー | インフルエンザウイルス再集合 |
| US10053671B2 (en) | 2014-06-20 | 2018-08-21 | Wisconsin Alumni Research Foundation (Warf) | Mutations that confer genetic stability to additional genes in influenza viruses |
| RU2605317C1 (ru) * | 2015-06-04 | 2016-12-20 | Федеральное государственное автономное образовательное учреждение высшего образования "Новосибирский национальный исследовательский государственный университет" (Новосибирский государственный университет, НГУ) | АДАПТИРОВАННЫЕ ПАНДЕМИЧЕСКИЕ ШТАММЫ ВИРУСА ГРИППА A/Tomsk/273/2010-MA1(H1N1pdm09), A/Tomsk/273/2010-MA2(H1N1pdm09) И A/Tomsk/273/2010-MA3(H1N1pdm09) ДЛЯ ОЦЕНКИ ДЕЙСТВИЯ ПРОТИВОВИРУСНЫХ ПРЕПАРАТОВ (ВАРИАНТЫ) |
| AU2016281904B2 (en) | 2015-06-26 | 2022-08-11 | Seqirus UK Limited | Antigenically matched influenza vaccines |
| WO2017005880A1 (en) | 2015-07-07 | 2017-01-12 | Seqirus UK Limited | Influenza potency assays |
| EP3341018A1 (en) | 2015-08-28 | 2018-07-04 | Wisconsin Alumni Research Foundation | Generation of infectious influenza viruses from virus-like particles |
| AU2017221444B2 (en) | 2016-02-19 | 2021-07-29 | Wisconsin Alumni Research Foundation (Warf) | Improved influenza B virus replication for vaccine development |
| KR102477492B1 (ko) * | 2016-07-15 | 2022-12-13 | 잇판사이단호진한다이비세이부쯔뵤우겐큐우카이 | 리소턴트 인플루엔자 바이러스 작출 방법 |
| WO2019044636A1 (ja) * | 2017-08-28 | 2019-03-07 | 一般財団法人阪大微生物病研究会 | リアソータントインフルエンザウイルスの段階的作出方法 |
| US11197926B2 (en) | 2017-10-25 | 2021-12-14 | Wisconsin Alumni Research Foundation (Warf) | Recombinant influenza viruses with stabilized HA for replication in eggs |
| WO2019086463A1 (en) | 2017-10-30 | 2019-05-09 | Baxalta GmbH | Environmentally compatible detergents for inactivation of lipid-enveloped viruses |
| US12343390B2 (en) | 2018-08-07 | 2025-07-01 | Wisconsin Alumni Research Foundation (Warf) | Recombinant biologically contained filovirus vaccine |
| US11389523B2 (en) | 2018-08-20 | 2022-07-19 | Wisconsin Alumni Research Foundation (Warf) | Vectors for eliciting immune responses to non-dominant epitopes in the hemagglutinin (HA) protein |
| CN113874496A (zh) | 2019-02-08 | 2021-12-31 | 威斯康星校友研究基金会(Warf) | 人源化细胞系 |
| WO2020223699A1 (en) | 2019-05-01 | 2020-11-05 | Wisconsin Alumni Research Foundation (Warf) | Improved influenza virus replication for vaccine development |
| JP7627911B2 (ja) | 2019-08-27 | 2025-02-07 | ウィスコンシン アルムニ リサーチ ファンデイション | 卵内複製のための安定化されたｈａを持つ組換えインフルエンザウイルス |
| WO2021150874A1 (en) | 2020-01-24 | 2021-07-29 | Wisconsin Alumni Research Foundation (Warf) | Recombinant influenza viruses with stabilized na |
| WO2021195410A1 (en) | 2020-03-25 | 2021-09-30 | Wisconsin Alumni Research Foundation (Warf) | Recombinant multivalent influenza viruses |
| JP7779858B2 (ja) * | 2020-04-29 | 2025-12-03 | エスケー バイオサイエンス カンパニー リミテッド | 使い捨て培養工程システムを用いたインフルエンザウイルス生産方法及びインフルエンザウイルス抗原精製条件の迅速確認試験 |
| US11694876B2 (en) | 2021-12-08 | 2023-07-04 | Applied Materials, Inc. | Apparatus and method for delivering a plurality of waveform signals during plasma processing |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0832638B2 (ja) | 1989-05-25 | 1996-03-29 | カイロン コーポレイション | サブミクロン油滴乳剤を含んで成るアジュバント製剤 |
| AU5543294A (en) | 1993-10-29 | 1995-05-22 | Pharmos Corp. | Submicron emulsions as vaccine adjuvants |
| DE19612966B4 (de) | 1996-04-01 | 2009-12-10 | Novartis Vaccines And Diagnostics Gmbh & Co. Kg | MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren |
| DE19612967A1 (de) | 1996-04-01 | 1997-10-02 | Behringwerke Ag | Verfahren zur Vermehrung von Influenzaviren in Zellkultur, sowie die durch das Verfahren erhältlichen Influenzaviren |
| TW570803B (en) | 1997-04-09 | 2004-01-11 | Duphar Int Res | Influenza vaccine |
| US6080725A (en) | 1997-05-20 | 2000-06-27 | Galenica Pharmaceuticals, Inc. | Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof |
| EP1098961B1 (en) | 1998-06-12 | 2008-01-16 | Mount Sinai School Of Medicine Of The City University Of New York | Interferon inducing genetically engineered attenuated viruses |
| AR025750A1 (es) | 1999-09-24 | 2002-12-11 | Smithkline Beecham Biolog | Vacunas |
| WO2001064846A1 (fr) | 2000-03-03 | 2001-09-07 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Cellule utilisable pour culture sans serum et culture en suspension, et procede de production de virus pour vaccin utilisant cette cellule |
| GB0024089D0 (en) | 2000-10-02 | 2000-11-15 | Smithkline Beecham Biolog | Novel compounds |
| US20040071734A1 (en) | 2001-02-23 | 2004-04-15 | Nathalie Garcon | Novel vaccine |
| WO2002067983A1 (en) | 2001-02-23 | 2002-09-06 | Glaxosmithkline Biologicals S.A. | Novel vaccine |
| TWI228420B (en) | 2001-05-30 | 2005-03-01 | Smithkline Beecham Pharma Gmbh | Novel vaccine composition |
| AU2004249133B2 (en) * | 2003-05-28 | 2009-05-28 | Wisconsin Alumni Research Foundation | High titer recombinant influenza viruses for vaccines and gene therapy |
| WO2005097181A1 (en) | 2004-04-05 | 2005-10-20 | Pfizer Products Inc. | Microfluidized oil-in-water emulsions and vaccine compositions |
| WO2005113756A1 (en) | 2004-05-14 | 2005-12-01 | Glaxosmithkline Biologicals S.A. | Method |
| US20080254067A1 (en) | 2004-05-20 | 2008-10-16 | Id Biomedical Corporation | Process for the Production of an Influenza Vaccine |
| CN103555670B (zh) | 2004-12-23 | 2015-08-12 | 米迪缪尼有限公司 | 用于病毒增殖的非致瘤性mdck细胞系 |
| US7691368B2 (en) | 2005-04-15 | 2010-04-06 | Merial Limited | Vaccine formulations |
| CA2613283A1 (en) | 2005-06-21 | 2007-01-04 | Medimmune Vaccines, Inc. | Methods and compositions for expressing a heterologous protease |
| US8703095B2 (en) | 2005-07-07 | 2014-04-22 | Sanofi Pasteur S.A. | Immuno-adjuvant emulsion |
| ES2359214T5 (es) | 2005-11-01 | 2014-10-08 | Novartis Vaccines And Diagnostics Gmbh | Vacunas virales derivadas de células con niveles reducidos de ADN celular residual por tratamiento con beta-propiolactona |
| BRPI0618254A2 (pt) | 2005-11-04 | 2011-08-23 | Novartis Vaccines & Diagnostic | emulsões com agente tensoativo de fase aquosa livre para fornecer adjuvante às vacinas contra influenza dividido |
| FR2896162B1 (fr) | 2006-01-13 | 2008-02-15 | Sanofi Pasteur Sa | Emulsion huile dans eau thermoreversible |
| JP2009532352A (ja) * | 2006-03-31 | 2009-09-10 | ダブリュエーアールエフ−ウィスコンシン アラムナイ リサーチ ファウンデーション | ワクチンのための高力価組み換えインフルエンザ・ウィルス |
| JP5491173B2 (ja) | 2006-04-19 | 2014-05-14 | メディミューン，エルエルシー | イヌ細胞中でマイナス鎖ウイルスｒｎａを発現させるための方法および組成物 |
| PT2086582E (pt) | 2006-10-12 | 2013-01-25 | Glaxosmithkline Biolog Sa | Vacina compreendendo uma emulsão adjuvante óleo em água |
| CN101553252A (zh) | 2006-12-06 | 2009-10-07 | 诺华有限公司 | 包含来自于四株流感病毒的抗原的疫苗 |
| EP2045323A1 (en) | 2007-10-05 | 2009-04-08 | Avir Green Hills Biotechnology Research Development Trade Ag | Linear expression constructs for production of influenza virus particles |
| ES2675771T3 (es) * | 2008-12-16 | 2018-07-12 | Ology Bioservices, Inc. | Producción de vacunas contra el virus de la gripe |
| EP2233152A1 (en) * | 2009-03-24 | 2010-09-29 | Avir Green Hills Biotechnology Research Development Trade Ag | High growth reassortant influenza A virus |
| CN102666860B (zh) | 2009-07-31 | 2015-06-17 | 诺华股份有限公司 | 反向遗传系统 |
| ES2813347T3 (es) * | 2009-10-26 | 2021-03-23 | Wisconsin Alumni Res Found | Virus recombinantes de la influenza de alto título con replicación mejorada en células Vero |
| ES2655051T3 (es) * | 2011-08-26 | 2018-02-16 | Wisconsin Alumni Research Foundation | Virus de la gripe con segmento génico PB2 mutante como vacunas vivas atenuadas |
-
2013
- 2013-03-02 ES ES13712156.2T patent/ES2628301T3/es active Active
- 2013-03-02 CA CA2813723A patent/CA2813723A1/en not_active Abandoned
- 2013-03-02 EP EP13712156.2A patent/EP2820126B1/en active Active
- 2013-03-02 AU AU2013205478A patent/AU2013205478B9/en active Active
- 2013-03-02 CN CN201380000396.3A patent/CN103608453B/zh active Active
- 2013-03-02 JP JP2013548864A patent/JP6054883B2/ja active Active
- 2013-03-02 WO PCT/EP2013/054227 patent/WO2013087945A2/en not_active Ceased
- 2013-06-03 US US13/909,013 patent/US9422528B2/en active Active
-
2015
- 2015-03-19 JP JP2015055989A patent/JP6279503B2/ja active Active
-
2016
- 2016-07-14 US US15/210,485 patent/US10245312B2/en active Active
-
2019
- 2019-02-11 US US16/272,018 patent/US20200000909A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015119730A5 (enExample) | ||
| JP7691380B2 (ja) | Ｍｄｃｋ、ベロ細胞又は卵内で増強された複製を有する高力価の組換えインフルエンザウイルス | |
| JP2016521553A5 (enExample) | ||
| EP1631663B1 (en) | High titer recombinant influenza viruses for vaccines and gene therapy | |
| JP2016509864A5 (enExample) | ||
| Szewczyk et al. | Introduction to molecular biology of influenza a viruses. | |
| EP2493912B1 (en) | High titer recombinant influenza viruses with enhanced replication in vero cells | |
| EP2010557B1 (en) | High titer recombinant influenza viruses for vaccines | |
| JP2011182797A5 (enExample) | ||
| US20140227310A1 (en) | Recombinant influenza virus highly expressing ha protein and preparation method and use thereof | |
| JP2016501020A5 (enExample) | ||
| Jang et al. | Principles underlying rational design of live attenuated influenza vaccines | |
| US20190203170A1 (en) | Avian Cells for Improved Virus Production | |
| CN104232594B (zh) | 重组类禽型h1n1流感病毒灭活疫苗株(js40/pr8)及其制备方法和应用 | |
| JP2014506785A5 (enExample) | ||
| TWI396741B (zh) | 非洲綠猴腎細胞培養之流感病毒及疫苗 | |
| CN101899461B (zh) | 一种编码甲型流感病毒NP蛋白和M2e多肽的融合基因 | |
| AU2013298632B2 (en) | Production of infectious influenza viruses | |
| CN105671002A (zh) | H9n2亚型禽流感病毒细胞高产疫苗株构建及应用 | |
| Gong et al. | Epitope variation in the Newcastle disease virus HN gene under antibody immune selective pressure in cell culture | |
| CN102234637A (zh) | 重组甲型h1n1流感病毒灭活疫苗株(sc/pr8)的制备及应用 | |
| Hartgroves et al. | Rapid generation of a well-matched vaccine seed from a modern influenza A virus primary isolate without recourse to eggs | |
| JP6748067B2 (ja) | インフルエンザウイルス作出用細胞 | |
| van Wielink et al. | Effect of natural and chimeric haemagglutinin genes on influenza A virus replication in baby hamster kidney cells | |
| Feng | Biological characterization of two evolutionarily related pathogens, equine and canine H3N8 influenza A viruses |